Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology

What Are the Long-Term Complications of FHH1?

At a Glance

FHH1 is almost always a benign, lifelong trait that does not cause symptoms. While rare long-term complications like bone thinning, joint pain, or pancreatitis can occur, routine yearly monitoring with blood work and DEXA scans ensures you stay healthy.

Familial hypocalciuric hypercalcemia type 1 (FHH1) is almost always a benign, lifelong genetic trait that typically does not cause noticeable symptoms or require treatment [1][2]. In fact, the primary reason doctors work so hard to diagnose FHH1 is to prevent unnecessary parathyroid surgery, as it is often mistaken for primary hyperparathyroidism, a more severe condition that requires surgical intervention [3]. Because FHH1 alters how the body senses calcium, patients walk around with slightly higher-than-average blood calcium levels every day [4].

While this mild hypercalcemia (high blood calcium) is generally harmless, in very rare circumstances, chronic exposure to elevated calcium can be linked to long-term issues such as weakened bones, joint pain, or inflammation of the pancreas [5][6]. Knowing about these rare possibilities is exactly why doctors recommend yearly monitoring like DEXA bone scans and routine blood work as a precaution.

Possible Rare Complications

Even though most people with FHH1 will never experience these problems, it is important to understand what to watch for:

Bone Mineral Density Changes (Osteoporosis)

Other disorders of high calcium—such as primary hyperparathyroidism or FHH type 3—are well-known for pulling calcium out of the bones, leading to weakened bones and osteoporosis [7][8]. In contrast, FHH1 is typically not associated with significant bone loss or metabolic bone disease [1][9]. However, doctors still monitor bone health because any prolonged calcium imbalance can occasionally impact bone mineral density over time [10][11]. Checking this regularly ensures that if bone weakening does occur, it is caught early.

Joint Pain (Chondrocalcinosis and Pseudogout)

Chronically high levels of calcium in the body can sometimes lead to calcium crystals depositing into the cartilage of joints—a condition known as chondrocalcinosis [6][12]. If these crystals trigger a sudden, severe inflammatory response, it causes an incredibly painful form of arthritis called pseudogout (calcium pyrophosphate deposition disease, or CPPD) [12].

  • What to watch for: Sudden, severe joint pain, swelling, redness, and warmth (often in the knees or wrists). While CPPD is more commonly linked to age or other metabolic conditions, younger patients with FHH1 experiencing these specific joint symptoms should be evaluated [13][14].

Pancreatitis

Acute pancreatitis is a sudden, painful inflammation of the pancreas, an organ that helps with digestion and blood sugar regulation. Elevated blood calcium is a known risk factor for triggering pancreatic injury and inflammation [15][16]. While this complication is much more frequently seen in other parathyroid diseases, clinical reports have documented rare instances of acute pancreatitis in patients with the genetic mutation that causes FHH1 [5][17].

  • What to watch for: Severe upper abdominal pain that may radiate to your back, accompanied by intense nausea and vomiting. This warrants an immediate trip to the emergency room or urgent care.

A Note on Daily Life and Diet

Because FHH1 is usually harmless, many patients wonder if they need to drastically change their diets, restrict calcium-rich foods like dairy, or stop taking vitamins. Generally, FHH1 does not require severe dietary restrictions or drinking excessive amounts of water, as your body’s “calcium thermostat” is simply set at a different baseline. However, you should always discuss your specific diet, hydration habits, and use of supplements (especially Vitamin D or calcium pills) with your endocrinologist to ensure they fit your unique health profile.

The Importance of Routine Monitoring

Because FHH1 usually causes no symptoms, long-term monitoring acts as a safety net. By checking in periodically, your medical team can ensure your condition remains stable [10][8]. Standard monitoring typically involves:

  • Yearly Blood Work: Checking your serum calcium, parathyroid hormone (PTH), and kidney function to ensure your calcium levels remain stable over time [8]. This also confirms that a separate, more aggressive calcium disorder hasn’t developed alongside FHH1.
  • Yearly DEXA Bone Scans: A DEXA scan (Dual-Energy X-ray Absorptiometry) is a quick, painless imaging test that measures bone thickness and strength. Getting this scan yearly, as recommended by your doctor, ensures your bones remain healthy despite the higher blood calcium [8][18].

While reading about complications can be intimidating, remember that FHH1 remains overwhelmingly benign [2]. These long-term screening steps simply offer peace of mind, proving year after year that your body is managing the condition well.

Common questions in this guide

Does FHH1 cause osteoporosis or bone loss?
FHH1 is generally not associated with significant bone loss or metabolic bone disease. However, because prolonged high calcium levels can occasionally impact bone mineral density over time, doctors recommend yearly DEXA scans to monitor your bone health.
Can FHH1 cause joint pain?
Yes, in rare cases, chronically high calcium levels can cause calcium crystals to deposit in joint cartilage. This can trigger a painful inflammatory arthritis called pseudogout, which causes sudden joint pain, swelling, redness, and warmth.
What are the signs of pancreas problems with FHH1?
Very rarely, the elevated blood calcium caused by FHH1 can trigger acute pancreatitis, which is a sudden inflammation of the pancreas. If you experience severe upper abdominal pain that radiates to your back, accompanied by intense nausea and vomiting, you should seek immediate emergency care.
Do I need to change my diet or avoid calcium if I have FHH1?
Most patients with FHH1 do not need to make drastic dietary changes or completely avoid calcium-rich foods. Your body's calcium thermostat is simply set at a different baseline, but you should discuss your specific diet and use of supplements with your endocrinologist.
What long-term monitoring is required for FHH1?
To ensure your condition remains stable, doctors typically recommend yearly blood work to check your calcium, parathyroid hormone, and kidney function. A yearly DEXA scan is also often advised to ensure your bones remain strong despite the higher blood calcium.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you recommend a yearly DEXA scan for me to track my bone mineral density, or do you prefer a different schedule based on my age and gender?
  2. 2.Should I adjust my intake of calcium-rich foods, or stop taking any over-the-counter vitamins and supplements?
  3. 3.What specific blood tests should we include in my yearly routine panel to ensure my FHH1 remains stable?
  4. 4.Are there any medications I am currently taking, such as blood pressure pills or diuretics, that could negatively interact with my calcium levels?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    A novel homozygous mutation of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.

    Li N, Li X, Ni XL, et al.

    Chinese medical journal 2021; (134(15)):1869-1871 doi:10.1097/CM9.0000000000001568.

    PMID: 34397587
  2. 2

    Nephrotic Syndrome Complicated with Familial Hypocalciuric Hypercalcemia in an Infant: A Case Report and Comprehensive Literature Review.

    Yu M, Xue M, Fan X, et al.

    Alternative therapies in health and medicine 2024;.

    PMID: 38702153
  3. 3

    Efficacy of calcium excretion and calcium/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

    Bhangu JS, Selberherr A, Brammen L, et al.

    Head & neck 2019; (41(5)):1372-1378 doi:10.1002/hed.25568.

    PMID: 30554440
  4. 4

    A novel homozygous c.301T > C, p.Y101H variant in the GNA11 gene is implicated in familial hypocalciuric hypercalcemia type 2 in a proband with the heterozygous variant present in mother and father - A case report.

    Koca SB, Balta B

    Scandinavian journal of clinical and laboratory investigation 2025; (85(8)):670-674 doi:10.1080/00365513.2025.2588772.

    PMID: 41240382
  5. 5

    A Rare Case of Familial Hypocalciuric Hypercalcemia in Patient With Pancreatitis.

    Khan MI, Jain T, Abid MM, et al.

    Journal of community hospital internal medicine perspectives 2025; (15(4)):66-68 doi:10.55729/2000-9666.1497.

    PMID: 40757212
  6. 6

    Acute Inflammatory Arthropathy and Hypercalcemia Leading to a Diagnosis of Primary Hyperparathyroidism in a Patient With Known Sarcoidosis.

    Larsen K, Guma J, Mehannek R, Guma M

    Cureus 2023; (15(6)):e41110 doi:10.7759/cureus.41110.

    PMID: 37519519
  7. 7

    Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis.

    Hannan FM, Babinsky VN, Thakker RV

    Journal of molecular endocrinology 2016; (57(3)):R127-42 doi:10.1530/JME-16-0124.

    PMID: 27647839
  8. 8

    [Asymptomatic primary hyperparathyroidism : Operation or observation?]

    Gollisch K, Siggelkow H

    Der Internist 2021; (62(5)):496-504 doi:10.1007/s00108-021-00996-0.

    PMID: 33710361
  9. 9

    Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population.

    Dershem R, Gorvin CM, Metpally RPR, et al.

    American journal of human genetics 2020; (106(6)):734-747 doi:10.1016/j.ajhg.2020.04.006.

    PMID: 32386559
  10. 10

    Cinacalcet therapy in symptomatic 11-year-old girl with familial hypocalciuric hypercalcemia type 3.

    Kołbuc M, Beck BB, Bukowska-Olech E, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(6)):1637-1640 doi:10.1007/s00467-025-07135-z.

    PMID: 41501259
  11. 11

    Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu).

    Chida A, Hasegawa Y, Segawa T, et al.

    Case reports in endocrinology 2025; (2025()):9514578 doi:10.1155/crie/9514578.

    PMID: 39949382
  12. 12

    Severe calcium pyrophosphate dihydrate deposition disease of the metacarpophalangeal joints.

    Rigsbee CA, Sizemore TC, Lohr KM

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-226132.

    PMID: 30269092
  13. 13

    Calcium Pyrophosphate Dihydrate Deposition Disease in Young Patients: Two Case Reports.

    Wickrematilake GW

    Archives of rheumatology 2017; (32(1)):80-83 doi:10.5606/ArchRheumatol.2017.6015.

    PMID: 30375521
  14. 14

    Update on calcium pyrophosphate deposition.

    Abhishek A, Doherty M

    Clinical and experimental rheumatology 2016; (34(4 Suppl 98)):32-8.

    PMID: 27586801
  15. 15

    Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation.

    Scheers I, Sokal E, Limaye N, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2019; (19(6)):801-804 doi:10.1016/j.pan.2019.07.045.

    PMID: 31391146
  16. 16

    Acute pancreatitis connected with hypercalcemia crisis in hyperparathyroidism: A case report.

    Ma YB, Hu J, Duan YF

    World journal of clinical cases 2019; (7(16)):2367-2373 doi:10.12998/wjcc.v7.i16.2367.

    PMID: 31531333
  17. 17

    Clinical review of acute, recurrent, and chronic pancreatitis: Recent updates of 2013-2019 literature.

    Sadiq N, Gillani SW, Al Saeedy D, et al.

    Journal of pharmacy & bioallied sciences 2020; (12(2)):112-123 doi:10.4103/jpbs.JPBS_313_19.

    PMID: 32742109
  18. 18

    Primary Hyperparathyroidism: Effects on Bone Health.

    Zanocco KA, Yeh MW

    Endocrinology and metabolism clinics of North America 2017; (46(1)):87-104 doi:10.1016/j.ecl.2016.09.012.

    PMID: 28131138

This page explains potential long-term complications of FHH1 for educational purposes only. Always consult your endocrinologist regarding your specific calcium levels, symptoms, and long-term monitoring plan.

Get notified when new evidence is published on Familial hypocalciuric hypercalcemia type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.